Zobrazeno 1 - 10 of 38 pro vyhledávání: '"Donina Sa"'
1
Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge
Autor: Anastasia Katelnikova, Donina Sa, Daria Mezhenskaya, Kirill Yakovlev, K. L. Kryshen, Konstantin V. Sivak, Valery Makarov, Victoria Matyushenko, Rekstin Ar, Larisa Rudenko, Irina Isakova-Sivak
Publikováno v: Viruses
Volume 13
Issue 7
Viruses, Vol 13, Iss 1280, p 1280 (2021)
The development of an influenza vaccine with broad protection and durability remains an attractive idea due to the high mutation rate of the influenza virus. An extracellular domain of Matrix 2 protein (M2e) is among the most attractive target for th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee8be254df8f28679b0722588482b38
https://pubmed.ncbi.nlm.nih.gov/34209093
Zobrazit plný text záznamu
2
Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
Autor: Rekstin Ar, E. V. Krutikova, Larisa Rudenko, Irina Kiseleva, Vera Krivitskaya, Erin Sparrow, Donina Sa, Ekaterina Stepanova, Maria Pisareva, Guido Torelli
Publikováno v: BioMed Research International, Vol 2018 (2018)
Background.Currently, two genetic lineages of influenza B virus, B/Victoria and B/Yamagata, are cocirculating in humans in various countries. This situation has raised a question regarding the possibility of cross-protection between B components of l
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1588510c9453962d591841f5c7eb7a5c
https://doi.org/10.1155/2018/9695628
Zobrazit plný text záznamu
4
Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
Autor: Anastasia Katelnikova, Rekstin Ar, Arman Muzhikyan, Irina Isakova-Sivak, Donina Sa, N V Larionova, Victoria Matyushenko, Konstantin V. Sivak, Irina Kiseleva, Larisa Rudenko, Tatiana Kotomina, E. V. Krutikova
The development of universal influenza vaccines, i.e. vaccines that can provide broad protection against seasonal and potentially pandemic influenza viruses, has been a priority for more than 20 years. Several approaches have been proposed that redir
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc0be28593b846d785f92512b001dee
Zobrazit plný text záznamu
5
Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
Autor: Igor Losev, Petukhova Gd, Alexandra Nikiforova, Marina Stukova, Donina Sa, Irina Isakova-Sivak, Anatoly Naykhin, Larisa Rudenko, Maureen Power, Mariana Erofeeva, Daniil Korenkov, Jorge Flores
Publikováno v: Human Vaccines & Immunotherapeutics
During the past decade, a number of H5 subtype influenza vaccines have been developed and tested in clinical trials, but most of them induced poor serum antibody responses prompting the evaluation of novel vaccination approaches. One of the most prom
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81959dab8275e9f297caa3d2923c581f
https://doi.org/10.1080/21645515.2015.1069931
Zobrazit plný text záznamu
6
Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
Autor: Tatiana Kotomina, Maria Pisareva, Irina Kiseleva, Ekaterina Bazhenova, E. V. Krutikova, Larisa Rudenko, Guido Torelli, Valery Makarov, Rekstin Ar, Erin Sparrow, Donina Sa, Ekaterina Stepanova, Anastasia Katelnikova, Arman Muzhikyan, Irina Isakova-Sivak
Publikováno v: Vaccines
Volume 6
Issue 4
Vaccines, Vol 6, Iss 4, p 74 (2018)
Influenza H7N9 virus is a potentially pandemic subtype to which most people are immunologically naï
ve. To be better prepared for the potential occurrence of an H7N9 pandemic, in 2017 the World Health Organization recommended developing cand
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b534806b65e8105c6576fc87be62b3c
http://europepmc.org/articles/PMC6313887
Zobrazit plný text záznamu
7
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model
Autor: Donina Sa, Ekaterina Stepanova, Erin Sparrow, Marie-Paule Kieny, Maria Pisareva, Irina Kiseleva, Marina N. Makarova, K. L. Kryshen, E. V. Krutikova, Arman Muzhikyan, Guido Torelli, Larisa Rudenko, Rekstin Ar, Elena Grigorieva
Publikováno v: PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0208028 (2018)
Background and aimThe majority of seasonal influenza vaccines are trivalent, containing two A virus strains (H1N1 and H3N2) and one B virus strain. The co-circulation of two distinct lineages of B viruses can lead to mismatch between the influenza B
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a7cbf8cc6182f6051feb07b0798a816
https://pubmed.ncbi.nlm.nih.gov/30507951
Zobrazit plný text záznamu
8
Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin
Autor: Daria Mezhenskaya, Irina Isakova-Sivak, Daniil Korenkov, Donina Sa, Florian Krammer, Tatiana Kotomina, Larisa Rudenko, Tatiana Smolonogina, Victoria Matyushenko
Publikováno v: Virology. 518
The development of influenza vaccines that can provide broad protection against all drifted seasonal virus variants, zoonotic infections and emerging pandemic strains, has been a priority for two decades. Here we propose a strategy of inducing broadl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e02bfddeee9f4c85f5e8a3363abf40a9
https://pubmed.ncbi.nlm.nih.gov/29574336
Zobrazit plný text záznamu
9
H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
Autor: Jorge Flores, Alexandra Nikiforova, Maria Pisareva, Tatiana Smolonogina, Maureen Power, Irina Dubrovina, Victoria Kuznetsova, Anatoly Naykhin, Larisa Rudenko, Donina Sa, Mariana Erofeeva, Petukhova Gd, Marina Stukova, Irina Isakova-Sivak, Irina Kiseleva
Publikováno v: Human Vaccines & Immunotherapeutics. 11:970-982
H2N2 influenza viruses have not circulated in the human population since 1968, but they are still being regularly detected in the animal reservoir, suggesting their high pandemic potential. To prepare for a possible H2N2 pandemic, a number of H2N2 va
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a58765e8750c09bf88c8a5dfc1bc1e48
https://doi.org/10.1080/21645515.2015.1010859
Zobrazit plný text záznamu
10
Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
Autor: Tatiana Bousse, Igor Losev, Svetlana Shcherbik, Larisa Rudenko, Irina Isakova-Sivak, Donina Sa, Daniil Korenkov, Tatiana Smolonogina, Rekstin Ar, Tatiana Tretiak, Petukhova Gd
Publikováno v: BioMed Research International, Vol 2017 (2017)
BioMed Research International
Since conserved viral proteins of influenza virus, such as nucleoprotein (NP) and matrix 1 protein, are the main targets for virus-specific CD8+ cytotoxic T-lymphocytes (CTLs), we hypothesized that introduction of the NP gene of wild-type virus into
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6441259370de0683b0e2045fdb6a1af6
https://doaj.org/article/b7f2c59d4bd64fcbb83a627c9c5efe73
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje